News

18th September 2023 Daniel Pfund, Senior Financial Analyst
Swatch Group or affordable luxury
11th September 2023 Hugues Chevalier, Economist
The colossal economic cost of climate inaction
4th September 2023 Olivier Aeschlimann, Senior Financial Analyst
Georg Fischer: strategic acquisition of Finland’s Uponor
26th June 2023 Daniel Pfund, Senior Financial Analyst
Roche obtains FDA approval for its anti-cancer drug Columvi
19th June 2023 Hugues Chevalier, Economist
China: growth stalls
12th June 2023 Olivier Aeschlimann, Senior Financial Analyst
UBS: takeover of CS finalized on June 12
5th June 2023 Daniel Pfund, Senior Financial Analyst
Swiss GDP: first quarter better than expected
30th May 2023 Olivier Aeschlimann, Senior Financial Analyst
Zurich Insurance: encouraging results
22nd May 2023 Hugues Chevalier, Economist
Tenth rate hike and another bank failure
15th May 2023 Daniel Pfund, Senior Financial Analyst
Swisscom: results in line with expectations

Loading...